Navigation Links
Nektar Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
Date:3/1/2011

7) 801-6888 (international) with a passcode of 10590598.

In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, or explained on the conference call, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.

About Nektar Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for Nektar's oral NKTR-118 late-stage development program to treat opioid-induced constipation and its NKTR-119 earlier stage development program for the treatment of pain without constipation side effects.  NKTR-181, a novel mu-opioid analgesic molecule, is scheduled to enter Phase 1 clinical studies in the first part of 2011.  In oncology, NKTR-102, a novel topoisomerase I-inhibitor, is being evaluated in Phase 2 clinical studies for the treatment of breast, ovarian and colorectal cancers. NKTR-105, a novel anti-mitotic agent, is in a Phase 1 clinical study in cancer patients with refractory solid tumors.

Nektar's technology has enabled seven approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including UCB's Cimzia(R) for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS(R) for hepatitis C and Amgen's Neulasta(R) for neutropenia.

Nektar is headquartered in San Francisco, California, with additional R&D operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nek
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar Therapeutics President and CEO Howard W. Robin to Present at the 31st Annual Cowen and Company Healthcare Conference in Boston
2. Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2010 on Tuesday, March 1, 2011, After Close of U.S.-Based Financial Markets
3. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
4. Nektar Therapeutics Reports Third Quarter 2010 Financial Results
5. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
6. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
7. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
8. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
9. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
10. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
11. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 2014 SynCardia Systems, Inc., has been recognized ... Small Companies presented by the Arizona Technology Council in ... 11th annual Governor,s Celebration of Innovation Awards honor technology ... Arizona Governor Jan Brewer ... was honored for its Freedom® portable driver, which powers ...
(Date:11/18/2014)... , Nov. 17, 2014  Nopras Technologies ... Stewart B. Rosenberg to the position ... Mr. Rosenberg joins Nopras from Bio-Investigations Ltd., a ... consultancy he founded 27 years ago, focused in ... care.  With undergraduate and graduate degrees in biology, ...
(Date:11/18/2014)... -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ("Zimmer") announced ... (the "EC") to extend the deadline for the EC,s ... limited number of days in order to provide the ... extensions are not uncommon in such in-depth investigations.  Zimmer ... facilitate their review of the pending transaction and is ...
Breaking Medicine Technology:SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 2SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 3Nopras Technologies Inc. Appoints Director Of Business Development - East Coast Operations 2Nopras Technologies Inc. Appoints Director Of Business Development - East Coast Operations 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 2Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 4Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 5
(Date:11/18/2014)... MONDAY, Nov. 17, 2014 (HealthDay News) -- Women who ... increased risk for chronic, severe menstrual pain, a new ... severe menstrual pain. While smoking has been suspected as ... has been inconclusive, the authors of the new study ... taking part in a long-term study of women,s health ...
(Date:11/18/2014)... Hills, CA (PRWEB) November 18, 2014 ... and workflow solutions, announced today their Gold sponsorship of ... November 19th through Friday, November 21st at the Fargo, ... event offering targeted Microsoft Dynamics GP training sessions and ... the Microsoft campus is an excellent way for users ...
(Date:11/18/2014)... 18, 2014 Recently, Wigsbuy has introduced its ... models are offered at greatly discounted prices now, up to ... stores of human hair products, offering many real and synthetic ... the global customers, Wigsbuy uses high quality materials to make ... up with the trend. , “We are offering a ...
(Date:11/18/2014)... By Dennis Thompson ... -- Heart attack and stroke patients can safely take aspirin ... The blood-thinning combination won,t increase a patient,s risk of early ... annual meeting of the American Heart Association in Chicago. The ... Lancet . Analysis of data from more than a ...
(Date:11/17/2014)... 2014 Vernon Brewer, Founder and President of ... two weeks and saw firsthand the devastating holocaust that ISIS ... Iraq and Syria. , “‘Holocaust’ is not a term I ... or driven thousands of Christians and members of other faiths ... is desperate. As ISIS expands, they continue to kill ...
Breaking Medicine News(10 mins):Health News:Study Ties Teen Smoking to Risk of Severe Menstrual Cramps 2Health News:Altec Joins the 2014 Great Plains User Conference (GPUC) as a Gold Sponsor, Demonstrating the Capabilities of Certified for Microsoft Dynamics Product doc-link 2Health News:Altec Joins the 2014 Great Plains User Conference (GPUC) as a Gold Sponsor, Demonstrating the Capabilities of Certified for Microsoft Dynamics Product doc-link 3Health News:It Is The Most Wonderful Time To Buy Full Lace Wigs At Wigsbuy.com 2Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 2Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 3Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 2Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 3
... , MONDAY, March 26 (HealthDay News) -- ... preserve their fertility while undergoing cancer treatment, a new ... with cancer need more information about fertility preservation methods ... Rosen, of the University of California, San Francisco, and ...
... --Teen girls are twice as likely as boys to use ... who analyzed in-car video clips of American teen drivers, behavior. ... driving behavior for both genders, but there were a number ... by the AAA Foundation for Traffic Safety. The video ...
... Results of a study presented at the Society of ... Calif., signal a light at the end of the ... (LAPC). A new procedure called irreversible electroporation or IRE ... tumor cells around a vast and delicate network of ...
... Physicians (ACP), representing 132,000 internal medicine specialists and medical student ... (ACA) has resulted in major improvements in access and coverage ... physicians. Considering that it is just a little over two ... of its programs are not yet fully effective, the ACA ...
... Brazil, Russia, India, China and South Africa are injecting ... in the world,s poorest countries, according to a report released ... many traditional donors reduce or slow their spending, the report ... and development. While all five countries have been ...
... intervention (PCI), also known as coronary angioplasty or angioplasty, ... PCI involves opening a blocked blood vessel by threading ... a stent is also inserted to keep the blood ... usually give patients medicine to prevent complications that may ...
Cached Medicine News:Health News:Few Young Women With Cancer Take Steps to Preserve Fertility 2Health News:Teen Girl Drivers Likelier to Use Electronic Devices: Study 2Health News:Electrical pulse treatment gives pancreatic cancer patients new hope 2Health News:The present and future of the Affordable Care Act 2Health News:The present and future of the Affordable Care Act 3Health News:The present and future of the Affordable Care Act 4Health News:BRICS bringing new resources and approaches to health and development as other donors lag 2Health News:BRICS bringing new resources and approaches to health and development as other donors lag 3Health News:Complications in patients undergoing PCI tend to occur within first 30 days 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: